Cervix carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
This study advances our understanding about the role of SOX14 and might explain the molecular mechanism by which this transcription factor could exert tumor suppressor properties in cervical carcinoma.
|
28926586 |
2017 |
Cervix carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
SOX1 and SOX14 are methylation biomarkers applicable for screening of all cervical cancer types.
|
27738327 |
2016 |
Mobius Syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Human SOX14 is localised to a 1.15-Mb yeast artificial chromosome on chromosome 3q23, close to loci for BPES (blepharophimosis, ptosis, epicanthus inversus syndrome) and Mobius syndrome.
|
10798354 |
2000 |
Mobius Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
This location places SOX14 within a chromosome interval associated with two distinct syndromes that affect craniofacial development: Blepharophimosis-ptosis-epicantus inversus syndrome and Möbius syndrome.
|
9925951 |
1998 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Recently, it became evident that SOX14 is one of four hypermethylated genes in cervical carcinoma, considered as a tumor suppressor candidate in this type of malignancy.
|
28926586 |
2017 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
This study advances our understanding about the role of SOX14 and might explain the molecular mechanism by which this transcription factor could exert tumor suppressor properties in cervical carcinoma.
|
28926586 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Recently, it became evident that SOX14 is one of four hypermethylated genes in cervical carcinoma, considered as a tumor suppressor candidate in this type of malignancy.
|
28926586 |
2017 |
Malignant tumor of cervix
|
0.010 |
Biomarker
|
disease |
BEFREE |
SOX1 and SOX14 are methylation biomarkers applicable for screening of all cervical cancer types.
|
27738327 |
2016 |
Cervical Adenocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Four markers (SLC6A5, SOX1, SOX14 and TBX20) detected ADC and SCC with similar sensitivity.
|
27738327 |
2016 |
cervical cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
SOX1 and SOX14 are methylation biomarkers applicable for screening of all cervical cancer types.
|
27738327 |
2016 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A set of seven potential markers (LRRN1, PRICKLE2, VHL, BHLHE40, RBSP3, CGGBP1 and SOX14) is promising for discrimination of ADC and SCC.
|
23478628 |
2013 |
Blepharophimosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Human SOX14 is localised to a 1.15-Mb yeast artificial chromosome on chromosome 3q23, close to loci for BPES (blepharophimosis, ptosis, epicanthus inversus syndrome) and Mobius syndrome.
|
10798354 |
2000 |
Limb defects
|
0.010 |
Biomarker
|
group |
BEFREE |
SOX14 is a candidate gene for limb defects associated with BPES and Möbius syndrome.
|
10798354 |
2000 |